IBDEI2GR ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,41336,0)
 ;;=I73.9^^189^2094^2
 ;;^UTILITY(U,$J,358.3,41336,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41336,1,3,0)
 ;;=3^Peripheral Vascular Disease,Unspec
 ;;^UTILITY(U,$J,358.3,41336,1,4,0)
 ;;=4^I73.9
 ;;^UTILITY(U,$J,358.3,41336,2)
 ;;=^184182
 ;;^UTILITY(U,$J,358.3,41337,0)
 ;;=M06.372^^189^2095^12
 ;;^UTILITY(U,$J,358.3,41337,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41337,1,3,0)
 ;;=3^Rheumatoid nodule, left Ankle/Foot
 ;;^UTILITY(U,$J,358.3,41337,1,4,0)
 ;;=4^M06.372
 ;;^UTILITY(U,$J,358.3,41337,2)
 ;;=^5010116
 ;;^UTILITY(U,$J,358.3,41338,0)
 ;;=M06.371^^189^2095^13
 ;;^UTILITY(U,$J,358.3,41338,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41338,1,3,0)
 ;;=3^Rheumatoid nodule, right Ankle/Foot
 ;;^UTILITY(U,$J,358.3,41338,1,4,0)
 ;;=4^M06.371
 ;;^UTILITY(U,$J,358.3,41338,2)
 ;;=^5010115
 ;;^UTILITY(U,$J,358.3,41339,0)
 ;;=M05.59^^189^2095^8
 ;;^UTILITY(U,$J,358.3,41339,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41339,1,3,0)
 ;;=3^Rheum polyneuropathy w/ rheum arthr mult site
 ;;^UTILITY(U,$J,358.3,41339,1,4,0)
 ;;=4^M05.59
 ;;^UTILITY(U,$J,358.3,41339,2)
 ;;=^5009976
 ;;^UTILITY(U,$J,358.3,41340,0)
 ;;=M05.572^^189^2095^7
 ;;^UTILITY(U,$J,358.3,41340,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41340,1,3,0)
 ;;=3^Rheum polyneuropathy w/ rheum arthr lft ank/ft
 ;;^UTILITY(U,$J,358.3,41340,1,4,0)
 ;;=4^M05.572
 ;;^UTILITY(U,$J,358.3,41340,2)
 ;;=^5009974
 ;;^UTILITY(U,$J,358.3,41341,0)
 ;;=M05.571^^189^2095^9
 ;;^UTILITY(U,$J,358.3,41341,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41341,1,3,0)
 ;;=3^Rheum polyneuropathy w/ rheum arthr rt ank/ft
 ;;^UTILITY(U,$J,358.3,41341,1,4,0)
 ;;=4^M05.571
 ;;^UTILITY(U,$J,358.3,41341,2)
 ;;=^5009973
 ;;^UTILITY(U,$J,358.3,41342,0)
 ;;=M05.471^^189^2095^6
 ;;^UTILITY(U,$J,358.3,41342,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41342,1,3,0)
 ;;=3^Rheum myopathy w/ rheum arthr rt ank/ft
 ;;^UTILITY(U,$J,358.3,41342,1,4,0)
 ;;=4^M05.471
 ;;^UTILITY(U,$J,358.3,41342,2)
 ;;=^5009950
 ;;^UTILITY(U,$J,358.3,41343,0)
 ;;=M05.472^^189^2095^5
 ;;^UTILITY(U,$J,358.3,41343,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41343,1,3,0)
 ;;=3^Rheum myopathy w/ rheum arthr lft ank/ft
 ;;^UTILITY(U,$J,358.3,41343,1,4,0)
 ;;=4^M05.472
 ;;^UTILITY(U,$J,358.3,41343,2)
 ;;=^5009951
 ;;^UTILITY(U,$J,358.3,41344,0)
 ;;=G90.523^^189^2095^1
 ;;^UTILITY(U,$J,358.3,41344,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41344,1,3,0)
 ;;=3^Regional Pain Syndrome,Bliateral Lower Limbs,Complex
 ;;^UTILITY(U,$J,358.3,41344,1,4,0)
 ;;=4^G90.523
 ;;^UTILITY(U,$J,358.3,41344,2)
 ;;=^5004169
 ;;^UTILITY(U,$J,358.3,41345,0)
 ;;=G90.522^^189^2095^2
 ;;^UTILITY(U,$J,358.3,41345,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41345,1,3,0)
 ;;=3^Regional Pain Syndrome,Lft Lower Limb,Complex
 ;;^UTILITY(U,$J,358.3,41345,1,4,0)
 ;;=4^G90.522
 ;;^UTILITY(U,$J,358.3,41345,2)
 ;;=^5133371
 ;;^UTILITY(U,$J,358.3,41346,0)
 ;;=G90.521^^189^2095^3
 ;;^UTILITY(U,$J,358.3,41346,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41346,1,3,0)
 ;;=3^Regional Pain Syndrome,Rt Lower Limb,Complex
 ;;^UTILITY(U,$J,358.3,41346,1,4,0)
 ;;=4^G90.521
 ;;^UTILITY(U,$J,358.3,41346,2)
 ;;=^5004168
 ;;^UTILITY(U,$J,358.3,41347,0)
 ;;=M06.272^^189^2095^10
 ;;^UTILITY(U,$J,358.3,41347,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41347,1,3,0)
 ;;=3^Rheumatoid Bursitis,Lft Ankle/Foot
 ;;^UTILITY(U,$J,358.3,41347,1,4,0)
 ;;=4^M06.272
 ;;^UTILITY(U,$J,358.3,41347,2)
 ;;=^5010092
 ;;^UTILITY(U,$J,358.3,41348,0)
 ;;=M06.271^^189^2095^11
 ;;^UTILITY(U,$J,358.3,41348,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41348,1,3,0)
 ;;=3^Rheumatoid Bursitis,Rt Ankle/Foot
